“The apprehension with using non IID listed ingredients is justified as it is extremely hard to evaluate if FDA would find the ‘novel excipient’ Protected to be used in a very drug product as there is no defined procedure for analysis and approval of excipients. The FDA steerage on https://fernandovogwm.bloguerosa.com/26264163/helping-the-others-realize-the-advantages-of-proleviate-includes-fda-approved-ingredients